Ken Griffin Clear Point Neuro, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 28,000 shares of CLPT stock, worth $422,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,000
Previous 20,700
35.27%
Holding current value
$422,240
Previous $111,000
181.98%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.81MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$18.7 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$6.99 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$5.65 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.53 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.03 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $369M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...